EDM 345: Attention Deficit Hyperactivity Disorder (ADHD) medication shortages

That this House expresses deep concern over the shortage and intermittent availability of ADHD medications such as concerta XL; notes the symptoms those with ADHD exhibit, such as difficulty focusing and acting without thinking, as well as the impacts of these on the daily functioning of individuals; further notes the disproportionate impact these symptoms have on children who, as a result of the disorder, face barriers in their education and general development; recognises the barriers faced by individuals suffering from ADHD in accessing employment opportunities; further recognises the potential stress and anxiety these medication shortages can have on individuals suffering from ADHD; sympathises with the experiences of those individuals, who often feel they are being overlooked and dismissed; and calls on the Government to do more to mitigate the issue of ADHD medication shortages.